- Home
- HUMA vs ACRE Comparison
HUMA vs ACRE Comparison
Compare HUMA & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- ACRE
- Stock Information
- Founded
- HUMA 2004
- ACRE 2011
- Country
- HUMA United States
- ACRE United States
- Employees
- HUMA N/A
- ACRE N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- ACRE Real Estate Investment Trusts
- Sector
- HUMA Health Care
- ACRE Real Estate
- Exchange
- HUMA Nasdaq
- ACRE Nasdaq
- Market Cap
- HUMA 250.2M
- ACRE 244.2M
- IPO Year
- HUMA N/A
- ACRE 2012
- Fundamental
- Price
- HUMA $1.51
- ACRE $4.72
- Analyst Decision
- HUMA Strong Buy
- ACRE Hold
- Analyst Count
- HUMA 8
- ACRE 6
- Target Price
- HUMA $10.88
- ACRE $5.31
- AVG Volume (30 Days)
- HUMA 5.9M
- ACRE 463.1K
- Earning Date
- HUMA 08-11-2025
- ACRE 08-05-2025
- Dividend Yield
- HUMA N/A
- ACRE 12.74%
- EPS Growth
- HUMA N/A
- ACRE N/A
- EPS
- HUMA N/A
- ACRE N/A
- Revenue
- HUMA $818,000.00
- ACRE $80,674,000.00
- Revenue This Year
- HUMA N/A
- ACRE N/A
- Revenue Next Year
- HUMA $949.92
- ACRE N/A
- P/E Ratio
- HUMA N/A
- ACRE N/A
- Revenue Growth
- HUMA N/A
- ACRE 58.54
- 52 Week Low
- HUMA $1.15
- ACRE $3.35
- 52 Week High
- HUMA $6.77
- ACRE $7.83
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- ACRE 55.57
- Support Level
- HUMA $1.43
- ACRE $4.51
- Resistance Level
- HUMA $1.67
- ACRE $4.68
- Average True Range (ATR)
- HUMA 0.15
- ACRE 0.14
- MACD
- HUMA -0.01
- ACRE 0.04
- Stochastic Oscillator
- HUMA 23.32
- ACRE 98.15
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.